Advertisement
Canada markets close in 6 hours 24 minutes

  • S&P/TSX

    21,926.02
    +40.64 (+0.19%)
     

  • S&P 500

    5,082.69
    +34.27 (+0.68%)
     

  • DOW

    38,129.91
    +44.11 (+0.12%)
     

  • CAD/USD

    0.7315
    -0.0008 (-0.11%)
     

  • CRUDE OIL

    84.35
    +0.78 (+0.93%)
     

  • Bitcoin CAD

    87,343.03
    +1,255.77 (+1.46%)
     

  • CMC Crypto 200

    1,380.41
    -16.12 (-1.15%)
     

  • GOLD FUTURES

    2,357.00
    +14.50 (+0.62%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     

  • NASDAQ

    15,826.90
    +215.14 (+1.38%)
     

  • VOLATILITY

    15.48
    +0.11 (+0.72%)
     

  • FTSE

    8,122.27
    +43.41 (+0.54%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6827
    +0.0006 (+0.09%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Today’s Research Reports on Aphria, Titan Medical, ProMIS Neurosciences and Cardiome Pharma

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Aphria Inc.
https://rdinvesting.com/news/?ticker=APH.TO

Titan Medical Inc.
https://rdinvesting.com/news/?ticker=TMD.TO

ProMIS Neurosciences, Inc.
https://rdinvesting.com/news/?ticker=PMN.TO

Cardiome Pharma Corp.
https://rdinvesting.com/news/?ticker=COM.TO

ADVERTISEMENT

Aphria's stock moved 6.42% lower Friday, to close the day at $10.20. The stock recorded a trading volume of 5,425,784 shares, which was above its three months average volume of 5,068,664 shares. In the last year, Aphria's shares have traded in a range of 4.55 - 24.75. The share price has gained 124.18% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $13.32 is greater than its 200-day moving average of $12.85. Shares of the company are trading at a Price to Earnings ratio of 57.95. Shares of Aphria have fallen approximately 45.45 percent year-to-date.

Access RDI's Aphria Inc. Research Report at:
https://rdinvesting.com/news/?ticker=APH.TO

On Friday, shares of Titan Medical recorded a trading volume of 161,975 shares, which was below the three months average volume of 818,848 shares. The stock ended the day flat at 0.23. The share price has gained 76.92% from its 52 week low with a 52 week trading range of 0.13 - 0.68. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.31 is below its 200-day moving average of $0.39. Shares of Titan Medical have fallen approximately 39.47 percent year-to-date.

Access RDI's Titan Medical Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TMD.TO

ProMIS Neurosciences' stock moved 3.66% higher Friday, to close the day at $0.42. The stock recorded a trading volume of 186,441 shares, which was below its three months average volume of 1,343,743 shares. In the last year, ProMIS Neurosciences' shares have traded in a range of 0.16 - 0.73. The share price has gained 165.63% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.45 is greater than its 200-day moving average of $0.33. Shares of ProMIS Neurosciences have gained approximately 112.50 percent year-to-date.

Access RDI's ProMIS Neurosciences, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=PMN.TO

On Friday, shares of Cardiome Pharma recorded a trading volume of 1,950 shares, which was below the three months average volume of 24,004 shares. The stock ended the day 0.34% lower at 2.97. The share price has gained 81.10% from its 52 week low with a 52 week trading range of 1.64 - 6.06. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.24 is greater than its 200-day moving average of $2.08. Shares of Inter Cardiome Pharma have gained approximately 55.50 percent year-to-date.

Access RDI's Inter Cardiome Pharma Corp. Research Report at:
https://rdinvesting.com/news/?ticker=COM.TO

Our Actionable Research on Aphria Inc. (TSX :APH.TO), Titan Medical Inc. (TSX :TMD.TO), ProMIS Neurosciences, Inc. (TSX :PMN.TO) and Cardiome Pharma Corp. (TSX :COM.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com